RecruitingPhase 4NCT05076110

Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures


Sponsor

Mayo Clinic

Enrollment

188 participants

Start Date

Apr 7, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This study is being conducted to evaluate the effectiveness of post-operative pain control without using narcotic pain medications.


Eligibility

Min Age: 16 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Acetaminophen, a drug called Gabapentin, and others for people with hip arthroscopy. The study is currently recruiting participants at 1 location. People eligible for this study include aged 16 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGOxycodone

5 mg tablets every 4 hours postoperatively as needed for pain control

DRUGIbuprofen

800 mg three times a day for 2 weeks postoperatively for pain control; not to exceed 3200 mg/day

DRUGGabapentin

300 mg three times a day for 5 days then wean off by day 10 postoperatively

DRUGAcetaminophen

1000 mg three times a day for up to 4 weeks postoperatively for pain control; not to exceed 4 grams per day

DRUGMethocarbamol

500 mg three times a week for 2 weeks postoperatively


Locations(1)

Mayo clinic

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05076110


Related Trials